Aiolos Bio Launches with $245 Million Series A Investment to …
Oct 24, 2023 · Aiolos launches with an oversubscribed $245 million Series A investment co-led by Atlas Venture, Bain Capital Life Sciences, Forbion, and Sofinnova Investments with additional …
OFF
Aiolos Bio Launches With $245 Million Series A Investment To …
2 days from now
Oct 24, 2023 · Aiolos launches with an oversubscribed $245 million Series A investment co-led by Atlas Venture, Bain Capital Life Sciences, Forbion, and Sofinnova Investments with additional …
businesswire.com
OFF
Forbion Co-leads $245 Million Series A Financing Of Aiolos
2 days from now
Oct 24, 2023 · SAN FRANCISCO AND LONDON – October 24, 2023 - Forbion, a leading European life sciences venture capital firm, today announces that it has co-led a $245 million …
forbion.com
OFF
Aiolos Bio Launches With $245 Million Series A Investment To …
2 days from now
Oct 24, 2023 · SAN FRANCISCO AND LONDON – October 24, 2023 – Aiolos Bio, Inc. (“Aiolos” or “the Company”) today announced its launch as a clinical-stage biopharmaceutical company …
baincapital.com
OFF
Aiolos Bio Launches With $245 Million Series A Investment To …
2 days from now
Oct 24, 2023 · Aiolos Bio Launches with $245 Million Series A Investment to Advance ...
yahoo.com
OFF
Aiolos Bio Raises $245M On Prospect Of Better Asthma Drug
2 days from now
Oct 24, 2023 · The drug came to Aiolos via China’s Jiangsu Hengrui Pharmaceuticals, from which the startup licensed AIO-001 in August. Aiolos’ approach is similar to that of Upstream Bio, …
biopharmadive.com
OFF
Forbion Portfolio Company Aiolos Bio, Inc. (Aiolos) To Be Acquired …
2 days from now
Jan 9, 2024 · This follows a $245 million Series A financing in Aiolos in October 2023, co-led by Forbion, alongside Atlas Venture, Bain Capital Life Sciences, and Sofinnova Investments with …
forbion.com
OFF
Aiolos Bio Launches With $245 Million Series A Investment To …
2 days from now
Aiolos Bio Launches with $245 Million Series A Investment to Advance Development of Novel, Phase 2-Ready TSLP Antibody. ... Bain Capital Life Sciences, Forbion, and Sofinnova …
vcaonline.com
OFF
Aiolos $245m Series A Heads Latest Crop Of Biotech Rounds
2 days from now
3 days ago · A new US biotech, Aiolos Bio, has drawn in an impressive $245 million in Series A financing that will help it complete clinical testing of lead drug AIO-001 for moderate-to-severe …
pharmaphorum.com
OFF
Aiolos Bio Launches With $245M Series A - Jacobsmgt.com
2 days from now
San Francisco & London, October 24, 2023 (Business Wire) -- Aiolos Bio, Inc. has launched as a clinical-stage biopharmaceutical company that aims to address the unmet respiratory and …
jacobsmgt.com
OFF
Aiolos Bio Launches With $245 Million Series A Investment To
2 days from now
Oct 24, 2023 · SAN FRANCISCO & LONDON--(BUSINESS WIRE)-- Aiolos Bio, Inc. (“Aiolos” or “the Company”) today announced its launch as a clinical-stage biopharmaceutical company …
biospace.com
OFF
Aiolos Bio Launches With $245 Million Series A Investment To …
2 days from now
Oct 24, 2023 · Developing a potentially best-in-class TSLP antibody (AIO-001) that is dosed every 6-months for patients with respiratory and inflammatory conditions Khurem Farooq, Co …
benzinga.com
OFF
Aiolos Bio Debuts With $245 Million Financing | The Pharmaletter
2 days from now
Oct 24, 2023 · San Francisco, USA-based biotech start-up Aiolos Bio has today emerged out of stealth, backed by an oversubscribed $245 million Series A investment. The company said the …
thepharmaletter.com
OFF
GSK, Moving Fast To Buy Aiolos, Pays $1B To Challenge Amgen ...
2 days from now
Jan 9, 2024 · Aiolos broke cover in late October, launching with a $245 million series A round co-led by Atlas Venture, Bain Capital Life Sciences, Forbion and Sofinnova Investments. ... Aiolos …
fiercebiotech.com
OFF
Aiolos Bio Launches With Ex-Gyroscope CEO At The Helm, Nearly …
2 days from now
Jan 16, 2024 · Aiolos Bio is jetting out of stealth with a $245 million series A, igniting its startup thrusters en route to a phase 2 trial for its lead asset to treat severe asthma. That asset, AIO …
biotech-today.com
OFF
JPM 2024: GSK Buys Aiolos Bio For $1.4 Billion, Cytokinetics ...
2 days from now
Jan 10, 2024 · Aiolos Won GSK’s Favor in Less Than 3 Months After Launch Launched in October 2023 with an oversubscribed $245 million Series A investment, Aiolos Bio is a clinical …
geneonline.com
OFF
Aiolos Bio Launches With $245M Series A Investment - Jacobs …
2 days from now
San Francisco and London, October 24, 2023 (Business Wire) -- Aiolos Bio, Inc. officially launches as a clinical-stage biopharmaceutical company, committed to addressing unmet …
jacobsmgt.com
OFF
GSK To Buy Asthma-focused Aiolos Bio In $1 Billion Deal - STAT
2 days from now
Jan 9, 2024 · GSK to acquire Aiolos Bio in $1.4 billion deal, picking up an experimental asthma drug. ... The company, which announced a $245 million Series A round in October, has been …
statnews.com
FAQs about Aiolos Bio Launches with $245 Million Series A Investment to … Coupon?
How much money did Aiolos bio raise?
Who invested in Aiolos?
Why did Aiolos bio invest $245 million in series a funds?
Who is Aiolos & how much does it cost?
Where is Aiolos based?
Is Aiolos bio launching a new asthma drug?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
